HealthEquity Quarterly Cash Flow Statement
NASDAQ: HQYConsumer DiscretionaryBusiness ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
HealthEquity free cash flow
In the quarter ended Jul 31, 2026, HealthEquity generated $136.2 million of operating cash flow and spent $978,000 on capital expenditures. That left free cash flow of $135.2 million, a free-cash-flow margin of 38.5% of revenue. Free cash flow was up 0.1% from the prior year's $135.1 million.
HealthEquity returned $107.7 million to shareholders through share repurchases, equal to 80% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
HealthEquity cash flow statement (quarterly)
| Quarter (USD) | Q2 20272026-07-31 | Q1 20272026-04-30 | Q4 20262026-01-31 | Q3 20262025-10-31 | Q2 20262025-07-31 | Q1 20262025-04-30 | Q4 20252025-01-31 | Q3 20252024-10-31 | Q2 20252024-07-31 | Q1 20252024-04-30 | Q4 20242024-01-31 | Q3 20242023-10-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 65.64M | 69.42M | 49.74M | 51.69M | 59.85M | 53.91M | 26.36M | 5.70M | 35.82M | 28.81M | 26.36M | 14.67M |
| Net Income growth (YoY) | +9.67% | +28.75% | +88.66% | +806.40% | +67.09% | +87.12% | +0.00% | -61.13% | +238.55% | +603.79% | — | — |
| Depreciation & Amortization | 41.95M | 38.21M | 38.68M | 38.78M | 38.45M | 38.74M | 39.18M | 40.72M | 43.61M | 38.94M | 37.91M | 37.78M |
| Stock-Based Compensation | 22.21M | 19.41M | 19.12M | 20.54M | 19.07M | 14.34M | 21.71M | 21.12M | 21.57M | 32.02M | 17.21M | 21.66M |
| Change in Working Capital | -13.80M | -10.87M | -3.69M | 4.64M | -17.06M | -530.00K | -27.28M | 16.91M | -1.74M | -3.90M | -26.52M | -14.23M |
| Operating Cash Flow | 136.16M | 97.53M | 117.92M | 138.57M | 135.87M | 64.74M | 75.75M | 90.55M | 108.13M | 65.43M | 77.07M | 57.11M |
| Capital Expenditures | -978.00K | -362.00K | -326.00K | -784.00K | -773.00K | -86.00K | -328.00K | -294.00K | -741.00K | -721.00K | -560.00K | -544.00K |
| Investing Cash Flow | -25.91M | -13.90M | -8.44M | -11.38M | -11.18M | -16.14M | -13.56M | -12.87M | -209.08M | -269.95M | -11.27M | -15.42M |
| Share Repurchases | -107.74M | -123.31M | -81.02M | -92.42M | -66.75M | -59.06M | -62.98M | -58.51M | 0 | 0 | 0 | — |
| Debt Issued | — | — | 0 | 0 | 0 | 0 | 0 | 511.88M | 175.00M | 50.00M | 0 | 0 |
| Debt Repaid | -11.88M | -15.00M | -25.00M | -25.00M | -50.00M | 0 | -25.00M | -536.88M | 0 | 0 | 0 | 0 |
| Financing Cash Flow | -119.61M | -137.18M | -99.81M | -122.40M | -108.12M | -56.65M | -88.41M | -82.42M | 176.62M | 51.77M | 4.12M | 2.03M |
| Net Change in Cash | -9.37M | -53.56M | 9.67M | 4.80M | 16.57M | -8.05M | -26.21M | -4.73M | 75.66M | -152.75M | 69.92M | 43.72M |
| Free Cash Flow | 135.18M | 97.16M | 117.59M | 137.79M | 135.09M | 64.65M | 75.42M | 90.26M | 107.39M | 64.71M | 76.51M | 56.56M |
This table shows 12 quarterly periods of HealthEquity's cash flow statement, from Q2 2027 back to Q3 2024, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow HQY's reporting calendar. What is a cash flow statement?